Ciprofol Versus Propofol for Anesthesia Induction in Cardiac Surgery: A Randomized Double-blind Controlled Clinical Trial - Trial NCT06312345
Access comprehensive clinical trial information for NCT06312345 through Pure Global AI's free database. This phase not specified trial is sponsored by Le Yu and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Le Yu
Shanghai East Hospital of Tongji University
Timeline & Enrollment
N/A
Mar 11, 2024
May 10, 2024
Primary Outcome
Mean arterial pressure,Mean arterial pressure,Mean arterial pressure,Mean arterial pressure,Heart beats,Heart beats,Heart beats,Heart beats
Summary
Ciprofol, a novel intravenous general anesthetic with a chemical structure akin to propofol,
 boasts significantly enhanced potency. It offers a rapid onset, reduced incidence of
 injection pain, and minor impact on the cardiovascular system. However, clinical research
 regarding ciprofol's use for anesthesia induction in cardiac surgery remains limited.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06312345
Non-Device Trial